News Headline Summary

Johnson & Johnson (JNJ) unit says Zytiga drug has received positive regulatory recommendation in the EU for the treatment of Metastatic Castration

19 Nov 2012 - 12:22 - Equities - Source: Newswires

Subscribe Now to RANsquawk

Click here for a 1 week free trial

RANsquawk provides audio news and commentary for over 15,000 professional traders and brokers worldwide. Services include: